Site/Language
EN CN JIAHERB
News
Grow Together and Work Together
2025 / 08
19

Research Progress on the Immunomodulatory Effects of Grape Seed Extract

 

1. Introduction 


Immunity is the core barrier for the body to resist diseases. With the high incidence of chronic inflammation, tumors, and infectious diseases, natural immunomodulators have attracted widespread attention. Grape Seed Extract (GSE), rich in polyphenols such as proanthocyanidins (PCs) and phenolic acids, contains over 80% oligomeric proanthocyanidins (OPCs). Due to their excellent antioxidant and immunomodulatory activities, OPCs have become a research focus. This article systematically reviews the immunomodulatory mechanisms and progress of GSE, providing a reference for developing natural immune intervention strategies. 

 

2. Main Components and In Vivo Metabolism 


2.1 Core Components 


The immunomodulatory activity of GSE is centered on oligomeric proanthocyanidins (OPCs), supplemented by phenolics such as catechin, epicatechin, and gallic acid. OPCs are polymers of 2–10 catechin units, with lower polymerization degrees (e.g., dimers, trimers) exhibiting stronger bioactivity. 

 

2.2 Metabolic Characteristics 


After oral intake, OPCs are degraded by gut microbiota into small phenolic acids (e.g., vanillic acid, phenylpropionic acid). Oligomers (≤4 units) can be directly absorbed in the small intestine. Upon entering the bloodstream, they bind to plasma proteins (>90% binding rate) and undergo hepatic glucuronidation/sulfation. Ultimately, 60% is excreted via urine and 40% via bile, with a half-life of 4–6 hours. Gut microbiota is critical for metabolism: Bifidobacterium enhances OPC degradation efficiency, while dysbiosis reduces bioavailability (by up to 35%). 

 

3. Core Mechanisms of Immune Enhancement 

 

3.1 Immune Cell Function Enhancement 


Innate Immunity: Promotes macrophage phagocytosis (upregulates CD36, TLR4 expression) and enhances NK cell cytotoxicity (increases perforin, granzyme B secretion). Adaptive Immunity: Modulates T-cell subset balance (increases Th1/Th2 ratio, promotes Treg differentiation) and stimulates B-cell production of IgG/IgA antibodies, restoring immune tolerance. 

 

3.2 Signaling Pathway Regulation 


 Antioxidant (Nrf2): Activates Nrf2 nuclear translocation, induces antioxidant enzymes (SOD, GSH-Px), and clears ROS in immune cells to reduce oxidative damage. 

Anti-inflammatory (NF-κB): Inhibits NF-κB phosphorylation, reduces pro-inflammatory cytokine release (TNF-α, IL-6), and alleviates chronic inflammation-induced immunosuppression. 

 Pattern Recognition (TLR): Modulates TLR2/4 signaling to enhance pathogen recognition and accelerate innate immune activation. 

 

3.3 Mucosal Immune Protection

 

OPCs bind to intestinal mucin glycoproteins, strengthening the gut barrier (increases tight junction protein Occludin expression) and reducing endotoxin influx. Concurrently, they promote intestinal IgA secretion, reinforcing the mucosal immune frontline (in animal studies, GSE increased intestinal IgA by 40%). 

 

4. Pharmacological Research on Immunomodulation 

 

4.1 Animal Studies: Disease Model Validation


Infection Model: GSE supplementation (100 mg/kg) in influenza-infected mice increased survival by 35% and reduced lung viral load by 58% (via enhanced NK activity and viral replication inhibition). 

Tumor Model: Oral GSE in tumor-bearing mice reduced tumor volume by 27% and increased CD8⁺T cell infiltration (by suppressing PD-L1 expression and reversing immunosuppressive microenvironments). 

Immunocompromised Model: GSE restored peripheral leukocyte counts (62% increase) and promoted splenic lymphocyte proliferation in cyclophosphamide-induced immunosuppressed mice. 

 

4.2 Human Studies: Preliminary Clinical Evidence 


Healthy Subjects: Daily supplementation with 200 mg OPCs for 8 weeks increased peripheral NK cell activity by 22% and salivary IgA by 18%. 

Suboptimal Health: Chronic fatigue syndrome patients taking GSE (150 mg/day) for 6 weeks showed a 30% decrease in IL-6 and improved fatigue symptoms. 

Limitations: Most studies involve small samples (<100 cases) and short durations (<12 weeks); long-term effects and dose-response relationships remain unclear. 

 

5. Safety Assessment 


5.1 Toxicological Profile 


 Acute Toxicity: Rat oral LD₅₀ >5 g/kg (practically non-toxic).  Long-Term Safety: In 24-week subchronic trials, rats fed 1 g/kg/day GSE showed no liver/kidney abnormalities, but high doses (>1.5 g/kg) may cause gastrointestinal irritation (diarrhea, nausea; ~8% incidence). 

 

5.2 Risk Precautions 


Drug Interactions: Potentiates anticoagulants (e.g., warfarin), increasing bleeding risk. 

Special Populations: Use cautiously in pregnant/lactating women and those with coagulation disorders. 

Recommended Dose: OPCs ≤300 mg/day in dietary supplements (based on current evidence). 

 

6. Conclusions and Prospects 

 

6.1 Conclusions 


GSE modulates immunity through multi-dimensional mechanisms: "strengthening immune cells, regulating signaling pathways, and protecting mucosal barriers." Animal and preliminary clinical studies validate its potential, but limitations persist: 

① Limited clinical scale and long-term data; 

② Complex composition with unclear monomeric activity differences; 

③ Unknown synergy with drugs/nutrients. 

 

6.2 Future Directions 


Precision Research: Analyze immunomodulatory differences among OPCs of varying polymerization degrees to identify optimal components. 

Clinical Expansion: Conduct large-scale trials across diseases (e.g., tumors, autoimmune disorders) and explore combination therapies. 

Delivery Technology: Develop nanocarriers to improve OPC stability and targeting (e.g., mucosa-targeted formulations for intestinal immunomodulation). 

As a natural immunomodulator, GSE holds promise for immune health and adjuvant therapy, but deeper mechanistic and clinical research is needed to support its application. 

 

References 

[1] Long M, Zhang Y, Li P, Yang SH, Zhang WK, Han JX, Wang Y, He JB. Intervention of Grape Seed Proanthocyanidin Extract on the Subchronic Immune Injury in Mice Induced by Aflatoxin B1. Int J Mol Sci. 2016 Apr 8;17(4):516. 

[2] Ali Rajput S, Sun L, Zhang N, Mohamed Khalil M, Gao X, Ling Z, Zhu L, Khan FA, Zhang J, Qi D. Ameliorative Effects of Grape Seed Proanthocyanidin Extract on Growth Performance, Immune Function, Antioxidant Capacity, Biochemical Constituents, Liver Histopathology and Aflatoxin Residues in Broilers Exposed to Aflatoxin B₁. Toxins (Basel). 2017 Nov 15;9(11):371. 

[3] Ma J, Fan X, Zhang W, Zhou G, Yin F, Zhao Z, Gan S. Grape Seed Extract as a Feed Additive Improves the Growth Performance, Ruminal Fermentation and Immunity of Weaned Beef Calves. Animals (Basel). 2023 Jun 5;13(11):1876. 

[4] Farahat MH, Abdallah FM, Ali HA, Hernandez-Santana A. Effect of dietary supplementation of grape seed extract on the growth performance, lipid profile, antioxidant status and immune response of broiler chickens. Animal. 2017 May;11(5):771-777.